Updated from 2:57 p.m. EDT
Widely held health care stocks took a beating Wednesday as a mess of earnings reports gave investors indigestion. GlaxoSmithKline(GSK) fell 5.3% to $29.29 after the company posted a 13% drop in first-quarter profit. Merck(GSK) shares were ailing a day after the company reported it had missed analysts' profit estimates and posted lower sales from the year-ago quarter. The stock fell 2.4% to $22.97. Schering-Plough(SGP) shares also fell, losing 2% to $21.67. Eli Lilly(LLY) shares fell 1.8% to $32.74. Pfizer(PFE) lost 3.6% to $13.04. Johnson & Johnson(JNJ) fell 2.4% to $51.18. Bristol-Myers Squibb(BMY) shares were down 0.8% to $19.85. Novo Nordisk(NVO) rose 1% to $45.99.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
-
4th UPDATE:House To Hold Standalone Vote On Health-Care Bill
FOXBusiness.com
-
Fair Game: Loan Pools That Need Some Sun
New York Times
-
Oil India, Indian Oil Said to Have Made Gulfsands Rejected Bid
BusinessWeek Online
-
Boy Charged in Wal-Mart Bias Case in New Jersey
New York Times
-
Economic Outlook: Review of Possible Downside Risks to Forecast
Calculated Risk
-
PIIGS Debt Coming Due
Calculated Risk
-
UN’s Ban Says Israeli Settlement Building Must End (Update4)
BusinessWeek Online
-
When drug makers' profits outweigh penalties
Washington Post
-
Solution to a thirsty world: sea water without the salt
Latest Business News from Times Online
-
Hunt for rogue trader over recycled carbon credits
Latest Business News from Times Online
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,741.98 | 1,159.90 | 2,374.41 | 36.87 |
Oil *
79.80
|
|
DOWN
37.19
|
DOWN
5.92
|
DOWN
16.87
|
UP
0.15
|
10 Yr
3.69%
SPDR Gold
108.28
|
|
-0.34%
|
-0.51%
|
-0.71%
|
+0.41%
|
Data delayed 20 minutes |
More From TheStreet
Latest Headlines
Brokerage Partners
Sponsored Links
